Skip to main content
Premium Trial:

Request an Annual Quote

PE Biosystems Creates Proteomics Center, Starts Two Collaborations



RAMINGHAM, Mass.--PE Biosystems said it will form a center for proteomics research at its PerSeptive Biosystems division here. The Proteomics Research Center will develop novel tools for proteomics, advance the science of proteomics, and create practical application-based systems for research, drug discovery and development, and health care.

PE Biosystems will develop value-added systems and Celera Genomics will generate protein information to give the proteomics effort a boost, said Tony White, PE’s chairman, president, and CEO. The proteomics center will use PerSeptive’s mass spectrometry technology along with products from other PE Biosystems divisions.

As part of the proteomics initiative, PE Biosystems has begun research collaborations with the University of Geneva and the University of Washington in Seattle to develop new proteomics technologies.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.